Lung neoplasm malignant
Not recruitingStudy of Atezolizumab and Dendritic Cell Vaccine for Maintenance Treatment in Patients with Extensive Stage Small Cell Lung Cancer
Study of Atezolizumab and Dendritic Cell Vaccine for Maintenance Treatment in Patients with Extensive Stage Small Cell Lung Cancer
- Disease:Lung neoplasm malignant
- Substances:AtezolizumabAutologous dendritic cells pulsed with allogeneic tumour cell lysate
Spain- Participants:18–64 years · 65+ years
- Substances:Atezolizumab
- Sponsor:Instituto Oncologico Dr. Rosell S.L.







